LEADER 00810nam0-2200289-i-450-
001 990005625730403321
005 20061020120943.0
035   $a000562573
035   $aFED01000562573
035   $a(Aleph)000562573FED01
035   $a000562573
100   $a19991006d1966----km-y0itay50------ba
101 1 $aita
105   $aa-------00---
200 1 $aArcheologia del Cinema$fdi C.W. Ceram
210   $aMilano$cArnoldo Mondadori$d©1966
215   $a267 p.$cill.$d24 cm
610 0 $aCinema$aTeoria e tecnica
676   $a791.43$v21$zita
700  1$aCeram,$bC. W.$f<1915-1972>$0274896
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990005625730403321
952   $a791.43 CER 1$bST.ARTE 7257$fFLFBC
959   $aFLFBC
996   $aArcheologia del Cinema$9604050
997   $aUNINA

LEADER 00967nam0-22003371i-450-
001 990002406300403321
005 20100621131839.0
010   $a88-7076-103-7
035   $a000240630
035   $aFED01000240630
035   $a(Aleph)000240630FED01
035   $a000240630
100   $a20030910d--------km-y0itay50------ba
101 0 $aita
200 1 $aTollerabilità di un farmaco$evalutazione clinica$fCristina Borghi, Davide Canti.
205   $a2. ed.
210   $aMilano$cOrganizzazione Editoriale Medico Farmaceutica$d1990.
215   $aIX, 233 p.$d24 cm
610 0 $aFarmaci
676   $a615.704 (ed. 19)
700  1$aBorghi,$bCristina$0101167
702  1$aCanti,$bDavide
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002406300403321
952   $a90 L 1A 17$bS.I.$fFMEBC
952   $a80 XIV B 20$b6809$fFFABC
959   $aFMEBC
959   $aFFABC
996   $aTollerabilità di un farmaco$9440762
997   $aUNINA